Protein kinase C activator
This page covers all Protein kinase C activator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Protein kinase C (PKC).
Targets
Marketed (2)
- ingenol mebutate 0.05% gel · Neal D. Bhatia, MD · Dermatology/Oncology
Ingenol mebutate activates protein kinase C (PKC) to induce rapid necrosis of actinic keratosis cells and promote immune-mediated clearance of damaged skin. - Inggenol Mebutate 0.015% · Goldman, Butterwick, Fitzpatrick and Groff · Dermatology
Ingenol mebutate activates protein kinase C (PKC) to induce rapid necrosis of actinic keratosis cells and trigger immune-mediated clearance of remaining lesions.
Phase 3 pipeline (2)
- Ingenol mebutate gel 0.05 % · LEO Pharma · Dermatology
Ingenol mebutate activates protein kinase C (PKC) to induce rapid necrosis of actinic keratosis cells and promote immune-mediated clearance of damaged skin. - Generic Ingenol Mebutate · Actavis Inc. · Dermatology/Oncology
Ingenol mebutate is a protein kinase C activator that induces rapid necrosis of treated cells and promotes immune-mediated destruction of remaining lesions.